Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic.

Molecular psychiatry - 1 Jul 2015

Lencz T, Malhotra A K

Abstract excerpt

The Psychiatric Genomics Consortium-Schizophrenia Workgroup (PGC-SCZ) has recently published a genomewide association study (GWAS) identifying >100 genetic loci, encompassing a total of 341 protein-coding genes, attaining genomewide significance for susceptibility to schizophrenia. Given the extremely long time (12-15 years) and expense (>$1 billion) associated with the development of novel drug targets,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Asian People
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Databases, Genetic

Share to Genome-Wide Association Study

Share to Pharmacogenetics

Share to Schizophrenia

Share to White People

Source

Open in PubMed Open full text

Identifiers

PMID: 25869805
DOI: 10.1038/mp.2015.28
PMCID: PMC4486648

Genes

PGC
CACNB2
DRD2
HCN1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic.PMID 25869805Read ↗

Identifying drug targets for schizophrenia through gene prioritizationSemantic proximity Read ↗

Identifying drug targets for schizophrenia through gene prioritization.Semantic proximity Read ↗

Integrating genome-wide association study and expression quantitative trait locus study identifies multiple genes and gene sets associated with schizophrenia.Semantic proximity Read ↗

Revisiting Antipsychotic Drug Actions Through Gene Networks Associated With Schizophrenia.Semantic proximity Read ↗

Genome-based drug discovery: prioritizing disease-susceptibility/disease-associated genes as novel drug targets for schizophrenia.Semantic proximity Read ↗

Genome-wide association studies of schizophrenia: does bigger lead to better results?Semantic proximity Read ↗

Gene-level analysis reveals the genetic aetiology and therapeutic targets of schizophrenia.Semantic proximity Read ↗

Gene-set analysis based on the pharmacological profiles of drugs to identify repurposing opportunities in schizophrenia.Semantic proximity Read ↗

Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.Semantic proximity Read ↗

Enhancing genetic discovery through narrow phenotyping in schizophrenia.Semantic proximity Read ↗

A comprehensive family-based replication study of schizophrenia genes.Semantic proximity Read ↗

Translating genome-wide association findings into new therapeutics for psychiatry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.